Atl1102 a Game Changer for DMD

DMD is caused by the lack of Dystrophen which is the primary cause.
Last weeks announcement which is yet to be recognised by the market. $$
Atl1102 Re DMD fulfils the secondary target (Disease progression ) which is Inflation and Fibrosis..
In combination with the present DMD drugs it does add to the efficacy to a point .( which Sarepta and others are looking for )
By the end of this 1/4 we will have the results . Can Atl1102 generate Dystrophen
Just a sniff of a positive result will send our Sp to 35c..( Game Changer)
Keep the Faith:
We Wait.